APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genetically Modified Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Genetically Modified Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchGenetically Modified Drug Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Genetically Modified Drug Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Genetically Modified Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genetically Modified Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Genetically Modified Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Genetically Modified Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Genetically Modified Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Genetically Modified Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genetically Modified Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Genetically Modified Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Genetically Modified Drug include Takeda, Sanofi, Johnson & Johnson, Novartis, Merck & Co., Roche, Eli Lilly, Pfizer and GlaxoSmithKline, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Genetically Modified Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Genetically Modified Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Genetically Modified Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Genetically Modified Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Genetically Modified Drug Segment by Company

Takeda

Sanofi

Johnson & Johnson

Novartis

Merck & Co.

Roche

Eli Lilly

Pfizer

GlaxoSmithKline

Baxter

Amgen

Pharming Group NV

LFB Biotechnologies SA

F. Hoffmann-La Roche

Abbott Laboratories

Genetically Modified Drug Segment by Type

Transgenic Animal

Transgenic Plant

Genetically Modified Drug Segment by Application

Hospital

Clinic

Genetically Modified Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetically Modified Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genetically Modified Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetically Modified Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Genetically Modified Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Genetically Modified Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Genetically Modified Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Genetically Modified Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Genetically Modified Drug Industry Trends Table 2. Genetically Modified Drug Industry Drivers Table 3. Genetically Modified Drug Industry Opportunities and Challenges Table 4. Genetically Modified Drug Industry Restraints Table 5. Global Genetically Modified Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Genetically Modified Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Genetically Modified Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Genetically Modified Drug Sales Market Share by Manufacturers Table 9. Global Genetically Modified Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Genetically Modified Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Genetically Modified Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Genetically Modified Drug Manufacturers, Product Type & Application Table 13. Global Genetically Modified Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Genetically Modified Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Transgenic Animal Table 17. Major Manufacturers of Transgenic Plant Table 18. Global Genetically Modified Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Genetically Modified Drug Sales by Type (2021-2026) & (k units) Table 20. Global Genetically Modified Drug Sales by Type (2027-2032) & (k units) Table 21. Global Genetically Modified Drug Sales Market Share by Type (2021-2026) Table 22. Global Genetically Modified Drug Sales Market Share by Type (2027-2032) Table 23. Global Genetically Modified Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Genetically Modified Drug Revenue by Type (2021-2026) & (k units) Table 25. Global Genetically Modified Drug Revenue by Type (2027-2032) & (k units) Table 26. Global Genetically Modified Drug Revenue Market Share by Type (2021-2026) Table 27. Global Genetically Modified Drug Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Genetically Modified Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Genetically Modified Drug Sales by Application (2021-2026) & (k units) Table 32. Global Genetically Modified Drug Sales by Application (2027-2032) & (k units) Table 33. Global Genetically Modified Drug Sales Market Share by Application (2021-2026) Table 34. Global Genetically Modified Drug Sales Market Share by Application (2027-2032) Table 35. Global Genetically Modified Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Genetically Modified Drug Revenue by Application (2021-2026) & (k units) Table 37. Global Genetically Modified Drug Revenue by Application (2027-2032) & (k units) Table 38. Global Genetically Modified Drug Revenue Market Share by Application (2021-2026) Table 39. Global Genetically Modified Drug Revenue Market Share by Application (2027-2032) Table 40. Global Genetically Modified Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Genetically Modified Drug Sales by Region (2021-2026) & (k units) Table 42. Global Genetically Modified Drug Sales Market Share by Region (2021-2026) Table 43. Global Genetically Modified Drug Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Genetically Modified Drug Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Genetically Modified Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 47. North America Genetically Modified Drug Sales by Country (2027-2032) & (k units) Table 48. Europe Genetically Modified Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 50. Europe Genetically Modified Drug Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Genetically Modified Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Genetically Modified Drug Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Genetically Modified Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Genetically Modified Drug Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Genetically Modified Drug Sales by Country (2027-2032) & (k units) Table 57. Global Genetically Modified Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Genetically Modified Drug Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Genetically Modified Drug Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Genetically Modified Drug Revenue Market Share by Region (2021-2026) Table 61. Global Genetically Modified Drug Revenue Market Share by Region (2027-2032) Table 62. Takeda Company Information Table 63. Takeda Business Overview Table 64. Takeda Genetically Modified Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Takeda Genetically Modified Drug Product Portfolio Table 66. Takeda Recent Development Table 67. Sanofi Company Information Table 68. Sanofi Business Overview Table 69. Sanofi Genetically Modified Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Sanofi Genetically Modified Drug Product Portfolio Table 71. Sanofi Recent Development Table 72. Johnson & Johnson Company Information Table 73. Johnson & Johnson Business Overview Table 74. Johnson & Johnson Genetically Modified Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Johnson & Johnson Genetically Modified Drug Product Portfolio Table 76. Johnson & Johnson Recent Development Table 77. Novartis Company Information Table 78. Novartis Business Overview Table 79. Novartis Genetically Modified Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Novartis Genetically Modified Drug Product Portfolio Table 81. Novartis Recent Development Table 82. Merck & Co. Company Information Table 83. Merck & Co. Business Overview Table 84. Merck & Co. Genetically Modified Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Merck & Co. Genetically Modified Drug Product Portfolio Table 86. Merck & Co. Recent Development Table 87. Roche Company Information Table 88. Roche Business Overview Table 89. Roche Genetically Modified Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Roche Genetically Modified Drug Product Portfolio Table 91. Roche Recent Development Table 92. Eli Lilly Company Information Table 93. Eli Lilly Business Overview Table 94. Eli Lilly Genetically Modified Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Eli Lilly Genetically Modified Drug Product Portfolio Table 96. Eli Lilly Recent Development Table 97. Pfizer Company Information Table 98. Pfizer Business Overview Table 99. Pfizer Genetically Modified Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Pfizer Genetically Modified Drug Product Portfolio Table 101. Pfizer Recent Development Table 102. GlaxoSmithKline Company Information Table 103. GlaxoSmithKline Business Overview Table 104. GlaxoSmithKline Genetically Modified Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. GlaxoSmithKline Genetically Modified Drug Product Portfolio Table 106. GlaxoSmithKline Recent Development Table 107. Baxter Company Information Table 108. Baxter Business Overview Table 109. Baxter Genetically Modified Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Baxter Genetically Modified Drug Product Portfolio Table 111. Baxter Recent Development Table 112. Amgen Company Information Table 113. Amgen Business Overview Table 114. Amgen Genetically Modified Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Amgen Genetically Modified Drug Product Portfolio Table 116. Amgen Recent Development Table 117. Pharming Group NV Company Information Table 118. Pharming Group NV Business Overview Table 119. Pharming Group NV Genetically Modified Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Pharming Group NV Genetically Modified Drug Product Portfolio Table 121. Pharming Group NV Recent Development Table 122. LFB Biotechnologies SA Company Information Table 123. LFB Biotechnologies SA Business Overview Table 124. LFB Biotechnologies SA Genetically Modified Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. LFB Biotechnologies SA Genetically Modified Drug Product Portfolio Table 126. LFB Biotechnologies SA Recent Development Table 127. F. Hoffmann-La Roche Company Information Table 128. F. Hoffmann-La Roche Business Overview Table 129. F. Hoffmann-La Roche Genetically Modified Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. F. Hoffmann-La Roche Genetically Modified Drug Product Portfolio Table 131. F. Hoffmann-La Roche Recent Development Table 132. Abbott Laboratories Company Information Table 133. Abbott Laboratories Business Overview Table 134. Abbott Laboratories Genetically Modified Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Abbott Laboratories Genetically Modified Drug Product Portfolio Table 136. Abbott Laboratories Recent Development Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Genetically Modified Drug Distributors List Table 140. Genetically Modified Drug Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Genetically Modified Drug Product Image Figure 2. Global Genetically Modified Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genetically Modified Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Genetically Modified Drug Sales (2021-2032) & (k units) Figure 5. Global Genetically Modified Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Genetically Modified Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Transgenic Animal Image Figure 9. Transgenic Plant Image Figure 10. Global Genetically Modified Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Genetically Modified Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Genetically Modified Drug Sales Market Share by Type (2021-2032) Figure 13. Global Genetically Modified Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Genetically Modified Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Genetically Modified Drug Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Genetically Modified Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Genetically Modified Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Genetically Modified Drug Sales Market Share by Application (2021-2032) Figure 21. Global Genetically Modified Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Genetically Modified Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Genetically Modified Drug Revenue Market Share by Application (2021-2032) Figure 24. North America Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Genetically Modified Drug Sales Market Share by Country (2021-2032) Figure 26. U.S. Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Genetically Modified Drug Sales Market Share by Country (2021-2032) Figure 31. Germany Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Genetically Modified Drug Sales Market Share by Country (2021-2032) Figure 38. China Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Genetically Modified Drug Sales Market Share by Country (2021-2032) Figure 46. Brazil Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Genetically Modified Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Genetically Modified Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Genetically Modified Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Figure 57. North America Genetically Modified Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Figure 59. Europe Genetically Modified Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Genetically Modified Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Genetically Modified Drug Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Genetically Modified Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Genetically Modified Drug Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Genetically Modified Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Transgenic Animal
  • Transgenic Plant
Applications
  • Hospital
  • Clinic
Companies covered
  • Takeda
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck & Co.
  • Roche
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Baxter
  • Amgen
  • Pharming Group NV
  • LFB Biotechnologies SA
  • F. Hoffmann-La Roche
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Genetically Modified Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Genetically Modified Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Genetically Modified Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Genetically Modified Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Genetically Modified Drug Market Dynamics
  1. 2.1 Genetically Modified Drug Industry Trends
  2. 2.2 Genetically Modified Drug Industry Drivers
  3. 2.3 Genetically Modified Drug Industry Opportunities and Challenges
  4. 2.4 Genetically Modified Drug Industry Restraints
3 Genetically Modified Drug Market by Manufacturers
  1. 3.1 Global Genetically Modified Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Genetically Modified Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Genetically Modified Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Genetically Modified Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Genetically Modified Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Genetically Modified Drug Manufacturers, Product Type & Application
  7. 3.7 Global Genetically Modified Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Genetically Modified Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Genetically Modified Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Genetically Modified Drug Tier 1, Tier 2, and Tier 3
4 Genetically Modified Drug Market by Type
  1. 4.1 Genetically Modified Drug Type Introduction
  2. 4.1.1 Transgenic Animal
  3. 4.1.2 Transgenic Plant
  4. 4.2 Global Genetically Modified Drug Sales by Type
  5. 4.2.1 Global Genetically Modified Drug Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Genetically Modified Drug Sales by Type (2021-2032)
  7. 4.2.3 Global Genetically Modified Drug Sales Market Share by Type (2021-2032)
  8. 4.3 Global Genetically Modified Drug Revenue by Type
  9. 4.3.1 Global Genetically Modified Drug Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Genetically Modified Drug Revenue by Type (2021-2032)
  11. 4.3.3 Global Genetically Modified Drug Revenue Market Share by Type (2021-2032)
5 Genetically Modified Drug Market by Application
  1. 5.1 Genetically Modified Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Genetically Modified Drug Sales by Application
  5. 5.2.1 Global Genetically Modified Drug Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Genetically Modified Drug Sales by Application (2021-2032)
  7. 5.2.3 Global Genetically Modified Drug Sales Market Share by Application (2021-2032)
  8. 5.3 Global Genetically Modified Drug Revenue by Application
  9. 5.3.1 Global Genetically Modified Drug Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Genetically Modified Drug Revenue by Application (2021-2032)
  11. 5.3.3 Global Genetically Modified Drug Revenue Market Share by Application (2021-2032)
6 Global Genetically Modified Drug Sales by Region
  1. 6.1 Global Genetically Modified Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Genetically Modified Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Genetically Modified Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Genetically Modified Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Genetically Modified Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Genetically Modified Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Genetically Modified Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Genetically Modified Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Genetically Modified Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Genetically Modified Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Genetically Modified Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Genetically Modified Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Genetically Modified Drug Revenue by Region
  1. 7.1 Global Genetically Modified Drug Revenue by Region
  2. 7.1.1 Global Genetically Modified Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Genetically Modified Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Genetically Modified Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Genetically Modified Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Genetically Modified Drug Revenue (2021-2032)
  8. 7.2.2 North America Genetically Modified Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Genetically Modified Drug Revenue (2021-2032)
  11. 7.3.2 Europe Genetically Modified Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Genetically Modified Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Genetically Modified Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Genetically Modified Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Genetically Modified Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Genetically Modified Drug Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Genetically Modified Drug Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Genetically Modified Drug Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Genetically Modified Drug Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Merck & Co.
  26. 8.5.1 Merck & Co. Company Information
  27. 8.5.2 Merck & Co. Business Overview
  28. 8.5.3 Merck & Co. Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck & Co. Genetically Modified Drug Product Portfolio
  30. 8.5.5 Merck & Co. Recent Developments
  31. 8.6 Roche
  32. 8.6.1 Roche Company Information
  33. 8.6.2 Roche Business Overview
  34. 8.6.3 Roche Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Roche Genetically Modified Drug Product Portfolio
  36. 8.6.5 Roche Recent Developments
  37. 8.7 Eli Lilly
  38. 8.7.1 Eli Lilly Company Information
  39. 8.7.2 Eli Lilly Business Overview
  40. 8.7.3 Eli Lilly Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Eli Lilly Genetically Modified Drug Product Portfolio
  42. 8.7.5 Eli Lilly Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Genetically Modified Drug Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 GlaxoSmithKline
  50. 8.9.1 GlaxoSmithKline Company Information
  51. 8.9.2 GlaxoSmithKline Business Overview
  52. 8.9.3 GlaxoSmithKline Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GlaxoSmithKline Genetically Modified Drug Product Portfolio
  54. 8.9.5 GlaxoSmithKline Recent Developments
  55. 8.10 Baxter
  56. 8.10.1 Baxter Company Information
  57. 8.10.2 Baxter Business Overview
  58. 8.10.3 Baxter Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Baxter Genetically Modified Drug Product Portfolio
  60. 8.10.5 Baxter Recent Developments
  61. 8.11 Amgen
  62. 8.11.1 Amgen Company Information
  63. 8.11.2 Amgen Business Overview
  64. 8.11.3 Amgen Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Amgen Genetically Modified Drug Product Portfolio
  66. 8.11.5 Amgen Recent Developments
  67. 8.12 Pharming Group NV
  68. 8.12.1 Pharming Group NV Company Information
  69. 8.12.2 Pharming Group NV Business Overview
  70. 8.12.3 Pharming Group NV Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Pharming Group NV Genetically Modified Drug Product Portfolio
  72. 8.12.5 Pharming Group NV Recent Developments
  73. 8.13 LFB Biotechnologies SA
  74. 8.13.1 LFB Biotechnologies SA Company Information
  75. 8.13.2 LFB Biotechnologies SA Business Overview
  76. 8.13.3 LFB Biotechnologies SA Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 LFB Biotechnologies SA Genetically Modified Drug Product Portfolio
  78. 8.13.5 LFB Biotechnologies SA Recent Developments
  79. 8.14 F. Hoffmann-La Roche
  80. 8.14.1 F. Hoffmann-La Roche Company Information
  81. 8.14.2 F. Hoffmann-La Roche Business Overview
  82. 8.14.3 F. Hoffmann-La Roche Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 F. Hoffmann-La Roche Genetically Modified Drug Product Portfolio
  84. 8.14.5 F. Hoffmann-La Roche Recent Developments
  85. 8.15 Abbott Laboratories
  86. 8.15.1 Abbott Laboratories Company Information
  87. 8.15.2 Abbott Laboratories Business Overview
  88. 8.15.3 Abbott Laboratories Genetically Modified Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Abbott Laboratories Genetically Modified Drug Product Portfolio
  90. 8.15.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Genetically Modified Drug Value Chain Analysis
  2. 9.1.1 Genetically Modified Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Genetically Modified Drug Production Mode & Process
  6. 9.2 Genetically Modified Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Genetically Modified Drug Distributors
  9. 9.2.3 Genetically Modified Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst